|Product Name||Sucrose (for injection)|
|Chemical Name||α-D-Glucopyranoside, β-D-fructofuranosyl-sucrose|
|EINECS Registration Number||200-334-9|
|CDE Record Registration Number||F20200000093|
|FDA DMF Number||35209|
|Grade||Pharmaceutical injection grade|
|Quality Standards||in line with national pharmacopoeia standards (Chp, USP, JP, EP)|
|Available Package Sizes||10kg,25kg|
Sucrose low endotoxin has a FDA DMF Number of 35209 and a CDE Record registration Number of F20200000093.
Low endotoxin sucrose is produced in an aseptic GMP environment and has an endotoxin level of less than 0.5 IU/g. It is suitable for injection purposes. The inclusion of low endotoxin trehalose dihydrate excipient in the formulation enhances the stability of biological molecules and minimizes the risk of adverse reactions in patients.
Can be used for antibodies, liposomes, vaccines and other biologics(e.g. mRNA-1273®, BNT162b2®, Enbrel®).
If you have any questions, please don't hesitate to contact us. We're always here to help with Pharmaceutical Excipients for your business. We can provide products ranging from grams to tons. AVT is able to produce and even register the product in US FDA according to your special needs.